Prelude Capital Management’s Pfizer PFE Stock Holding History

Prelude Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,300	Closed	-$241K	–	1967
2021 Q2	$241K	Sell	7,300 -8,200	-53%	-$319K	0.01%	1309
2021 Q1	$562K	Sell	15,500 -42,500	-73%	-$1.51M	0.01%	842
2020 Q4	$2.13M	Buy	+58,000	New	+$2.13M	0.05%	281
2020 Q3	–	Sell	-2,951	Closed	-$92K	–	2222
2020 Q2	$92K	Sell	2,951 -843	-22%	-$28.6K	0.01%	981
2020 Q1	$118K	Sell	3,794 -48,063	-93%	-$1.64M	0.01%	556
2019 Q4	$1.93M	Sell	51,857 -41,106	-44%	-$1.46M	0.07%	229
2019 Q3	$3.17M	Buy	+92,963	New	+$3.38M	0.14%	99
2019 Q2	–	Sell	-26,350	Closed	-$1.06M	–	2039
2019 Q1	$1.06M	Buy	+26,350	New	+$1.06M	0.06%	317
2018 Q1	–	Sell	-71,672	Closed	-$2.46M	–	1669
2017 Q4	$2.46M	Buy	+71,672	New	+$2.44M	0.2%	102
2016 Q4	–	Sell	-40,052	Closed	-$1.29M	–	1729
2016 Q3	$1.29M	Buy	+40,052	New	+$1.34M	0.14%	172
2015 Q4	–	Sell	-1,054	Closed	-$31K	–	1632
2015 Q3	$31K	Buy	+1,054	New	+$33.8K	﹤0.01%	1165
2014 Q2	–	Sell	-22,239	Closed	-$678K	–	2108
2014 Q1	$678K	Buy	+22,239	New	+$663K	0.09%	302

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Prelude Capital Management's PFE Position: Q1 2026 in Review

Prelude Capital Management increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $402K and bringing the position to 134,252 shares worth $3.77M. The position accounts for 0.29% of the portfolio, ranked #86.

Prelude Capital Management first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $3.91M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Prelude Capital Management held 134,252 shares of Pfizer worth $3.77M as of Q1 2026.
Prelude Capital Management bought 15,110 Pfizer shares in Q1 2026, an estimated $402K.
Pfizer made up 0.29% of Prelude Capital Management's portfolio in Q1 2026, its #86 holding.
Prelude Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
Prelude Capital Management's Pfizer position peaked at $3.91M in Q4 2021.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.